{
    "clinical_study": {
        "@rank": "111104", 
        "acronym": "PARROT", 
        "arm_group": [
            {
                "arm_group_label": "Rotigotine", 
                "arm_group_type": "Experimental", 
                "description": "80 patients with late onset PD are randomized in 2 parallel groups, ratio 1:1."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This exploratory trial will fulfill  a medical data gap for the dopamine-agonist rotigotine,\n      as so far no data on elderly population is available.\n\n      Primary objective: To assess efficacy and safety of rotigotine in patients with late onset\n      Parkinson's Disease (PD), starting at age 70 or later, on motor symptoms.\n\n      Secondary objective: To assess efficacy and safety of rotigotine in patients with late onset\n      Parkinson's Disease (PD), starting at age 70 or later, on selected non motor symptoms :\n      sleep quality; depression; cognitive function.\n\n      Subjects \u226570 years, with diagnosis of Parkinson's Disease (PD) based on the presence of at\n      least two of three cardinal features (bradykinesia, resting tremor, rigidity), within 12\n      months since diagnosis and no longer than 12 months from onset to diagnosis, and for whom\n      the caring physician is uncertain on whether or not to start treatment.\n\n      Outcome Measurement: Percentage of Responders to treatment in motor (part III) and\n      Activities of daily living (ADL) (part II) components of Unified Parkinson's Disease Rating\n      Scale (UPDRS) at visit 4 and 6; Percentage of Responders to treatment in sleep quality in\n      relation to Parkinson's Disease Sleep Scale (PDSS)-2 at visit 4 and 6;  Responders to\n      treatment in mood in relation to Geriatric Depression Scale (GDS) at visit 4 and 6.\n\n      Exploratory, randomized, double blind, placebo-controlled study: 80 patients with late onset\n      Parkinson's Disease (PD) are randomized in 2 parallel groups, ratio 1:1.\n\n      One group will be treated with rotigotine and one group will be treated with placebo, for 12\n      weeks after titration."
        }, 
        "brief_title": "Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease", 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "detailed_description": {
            "textblock": "Treatment is titrated to optimal dose (that at which investigator and subject felt that\n      motor and non motor impairment are adequately controlled), starting at 2 mg/24 hr and\n      increasing with weekly increments of 2 mg/24 hr up to a maximum of 8 mg/24 hr. The dose is\n      maintained at the optimal or maximal dose for a 8-week period (maintenance period) ."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u226570 years\n\n          -  Idiopathic Parkinson's Disease (PD) confirmed by at least two of the following signs:\n             resting tremor, bradykinesia, rigidity\n\n          -  Diagnosis of Parkinson's Disease (PD) within the last 12 months and onset of symptoms\n             within 12 months from diagnosis\n\n          -  Disease stage I or II according to Hoehn and Yahr Scale\n\n          -  Ability to provide written informed consent\n\n          -  Patients willing and able to comply with scheduled visits, treatment plan, laboratory\n             tests and other study procedures\n\n        Exclusion Criteria:\n\n          -  Disease duration more than 12 months since diagnosis and/or duration of symptoms at\n             diagnosis for more than 12 months\n\n          -  Hoehn & Yahr stage \u22653\n\n          -  Atypical or secondary parkinsonism\n\n          -  Patient currently on L-dopa, Dopamine Agonist (DA) or other Parkinson's Disease (PD)\n             medication at baseline\n\n          -  Centrally acting dopaminergic agents, monoamine oxidase inhibitors (MAOIs),\n             tolcapone, budipine, neuroleptics taken within the 28 days preceding the baseline\n             visit\n\n          -  History of deep brain stimulation\n\n          -  History of severe cardiac disease/heart failure in the last 3 years\n\n          -  History of repeated falls\n\n          -  History of sulfite sensitivity\n\n          -  Arterial hypotension\n\n          -  Stroke or a transient ischemic attack within the last 12 months\n\n          -  Previous or current treatment with rotigotine (at any time)\n\n          -  Diagnosis of dementia according to Diagnostic and Statistic Manual (DSM)-IV-Revised\n\n          -  Mini Mental State Examination (MMSE) total score <24 at screening  visit\n\n          -  History of psychosis\n\n          -  Clinically relevant hepatic dysfunction and/or transaminase levels 5+ times higher\n             than upper normal value\n\n          -  Experimental treatments within the antecedent 3 months\n\n          -  History of drug or alcohol dependency\n\n          -  Poor compliance with treatment\n\n          -  Inability to comply with protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "70 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103465", 
            "org_study_id": "EudraCT Number: 2013-000827-15"
        }, 
        "intervention": {
            "arm_group_label": "Rotigotine", 
            "description": "transdermal patch", 
            "intervention_name": "Rotigotine", 
            "intervention_type": "Drug", 
            "other_name": "Neupro"
        }, 
        "intervention_browse": {
            "mesh_term": "N 0437"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Parkinson's Disease", 
            "treatment", 
            "old patients", 
            "Rotigotine"
        ], 
        "lastchanged_date": "April 1, 2014", 
        "location": [
            {
                "contact": {
                    "email": "parkbari@hotmail.com", 
                    "last_name": "Michele De Mari, Dr", 
                    "phone": "3492112829"
                }, 
                "facility": {
                    "address": {
                        "city": "Andria", 
                        "country": "Italy", 
                        "state": "Andria-Barletta-Trani", 
                        "zip": "76123"
                    }, 
                    "name": "Ospedale Lorenzo Bonomo Andria"
                }, 
                "investigator": {
                    "last_name": "Michele De Mari, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "filippo.tamma@miulli.it", 
                    "last_name": "Filippo Tamma, Dr", 
                    "phone": "3492410782"
                }, 
                "facility": {
                    "address": {
                        "city": "Acquaviva Delle Fonti", 
                        "country": "Italy", 
                        "state": "Bari", 
                        "zip": "70021"
                    }, 
                    "name": "Ospedale Generale Regionale \"F. Miulli\""
                }, 
                "investigator": {
                    "last_name": "Filippo Tamma, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "f.valluzzi@alice.it", 
                    "last_name": "Francesco Valluzzi, Dr", 
                    "phone": "3280943406"
                }, 
                "facility": {
                    "address": {
                        "city": "Monopoli", 
                        "country": "Italy", 
                        "state": "Bari", 
                        "zip": "70043"
                    }, 
                    "name": "Ospedale S. Giacomo"
                }, 
                "investigator": {
                    "last_name": "Francesco Valluzzi, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "d.fogli@operapadrepio.it", 
                    "last_name": "Danilo Fogli, Dr", 
                    "phone": "3934309154"
                }, 
                "facility": {
                    "address": {
                        "city": "San Giovanni Rotondo", 
                        "country": "Italy", 
                        "state": "Foggia", 
                        "zip": "71013"
                    }, 
                    "name": "IRCCS \"Casa Sollievo della Sofferenza\""
                }, 
                "investigator": {
                    "last_name": "Danilo Fogli, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "enzotoni@alice.it", 
                    "last_name": "Vincenzo Toni, Dr", 
                    "phone": "3470526794"
                }, 
                "facility": {
                    "address": {
                        "city": "Casarano", 
                        "country": "Italy", 
                        "state": "Lecce", 
                        "zip": "73042"
                    }, 
                    "name": "Ospedale Francesco Ferrari"
                }, 
                "investigator": {
                    "last_name": "Vincenzo Toni, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "giancarlo.logroscino@gmail.com", 
                    "last_name": "Giancarlo Logroscino, Prof", 
                    "phone": "3394217992"
                }, 
                "facility": {
                    "address": {
                        "city": "Tricase", 
                        "country": "Italy", 
                        "state": "Lecce", 
                        "zip": "73039"
                    }, 
                    "name": "A.O. Ospedale \"Card. G. Panico\" di Tricase"
                }, 
                "investigator": {
                    "last_name": "Giancarlo Logroscino, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "giovanni.defazio@uniba.it", 
                    "last_name": "Giovanni Defazio, Prof", 
                    "phone": "0805478511"
                }, 
                "facility": {
                    "address": {
                        "city": "Bari", 
                        "country": "Italy", 
                        "zip": "70124"
                    }, 
                    "name": "Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari"
                }, 
                "investigator": {
                    "last_name": "Giovanni Defazio, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "enxitp@tin.it", 
                    "last_name": "Bruno Passarella, Dr", 
                    "phone": "0831 537318"
                }, 
                "facility": {
                    "address": {
                        "city": "Brindisi", 
                        "country": "Italy", 
                        "zip": "72100"
                    }, 
                    "name": "Ospedale \"A. Perrino\""
                }, 
                "investigator": {
                    "last_name": "Bruno Passarella, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "lmsc70@hotmail.com", 
                    "last_name": "Luigi Maria Specchio, Prof", 
                    "phone": "3381038704"
                }, 
                "facility": {
                    "address": {
                        "city": "Foggia", 
                        "country": "Italy", 
                        "zip": "71100"
                    }, 
                    "name": "A.O. Universitaria \"Ospedali Riuniti\"-U.O. Neurologia Universitaria"
                }, 
                "investigator": {
                    "last_name": "Luigi Maria Specchio, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "cmundi@ospedaliriunitifoggia.it", 
                    "last_name": "Ciro Mundi, Dr", 
                    "phone": "3299367148"
                }, 
                "facility": {
                    "address": {
                        "city": "Foggia", 
                        "country": "Italy", 
                        "zip": "71100"
                    }, 
                    "name": "A.O. Universitaria \"Ospedali Riuniti\" - U.O. Neurologia Ospedaliera"
                }, 
                "investigator": {
                    "last_name": "Ciro Mundi, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "trianni.giorgio@libero.it", 
                    "last_name": "Giorgio Trianni, Dr", 
                    "phone": "339 6069513"
                }, 
                "facility": {
                    "address": {
                        "city": "Lecce", 
                        "country": "Italy", 
                        "zip": "73100"
                    }, 
                    "name": "Presidio Ospedaliero \"Vito Fazzi\""
                }, 
                "investigator": {
                    "last_name": "Giorgio Trianni, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Late Onset Parkinson's Disease in Subjects 70 Years and Older: Possible Use of Rotigotine", 
        "other_outcome": {
            "description": "(*)  Responder  to treatment is a subject who has at least a 20% decrease in the sum of scores (parts II and III) from the Unified Parkinson's Disease Rating Scale (UPDRS) subtotal from baseline to the end of the maintenance phase in the direction of normality.\nThe outcome will be valuate on Month 2 and Month 4", 
            "measure": "Responders to treatment in mood in relation to Geriatric Depression Scale  (GDS) at visit 4 and 6", 
            "safety_issue": "No", 
            "time_frame": "M2"
        }, 
        "overall_contact": {
            "email": "elisabetta.pupillo@marionegri.it", 
            "last_name": "Elisabetta Pupillo, PharmD", 
            "phone": "3391693675"
        }, 
        "overall_official": {
            "affiliation": "A.O. Ospedale \"Card G. Panico\" di Tricase", 
            "last_name": "Giancarlo Logroscino, Prof", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: The Italian Medicines Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "(*)  Responder  to treatment is a subject who has at least a 20% decrease in the sum of scores (parts II and III) from the Unified Parkinson's Disease Rating Scale (UPDRS) subtotal from baseline to the end of the maintenance phase in the direction of normality.\nThe outcome will be valuate on Month 2 and Month 4", 
            "measure": "Percentage of Responders to treatment (*) in motor (part III) and Activities of daily living (ADL) (part II) components of Unified Parkinson's Disease Rating Scale (UPDRS) at visit 4 and 6", 
            "safety_issue": "No", 
            "time_frame": "M2"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103465"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "(*)  Responder  to treatment is a subject who has at least a 20% decrease in the sum of scores (parts II and III) from the Unified Parkinson's Disease Rating Scale (UPDRS) subtotal from baseline to the end of the maintenance phase in the direction of normality The outcome will be valuate on Month 2 and Month 4", 
            "measure": "Percentage of Responders to treatment in sleep quality in relation to Parkinson's Disease Sleep Scale-2 (PDSS) at visit 4 and 6", 
            "safety_issue": "No", 
            "time_frame": "M2"
        }, 
        "source": "Azienda Ospedaliera Cardinale G. Panico", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Azienda Ospedaliera Cardinale G. Panico", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}